Therapeutic trials for systemic sclerosis: An update. The overwhelming need in this disease is to diagnose it early and identify those patients who will benefit most from early, aggressive treatment. We attempt to review data from recent clinical trials and the lessons derived. Indian Journal of Dermatology, Venereology and Leprology. 2008 Vol 74 Issue 5 Page : 436-446.
Systemic Scleroderma Symptoms. Most of the proven or accepted treatments for scleroderma symptoms are found on the individual symptom pages. See the master listing of scleroderma symptoms or use our internal site search (above) to find the latest information and treatments. The best recommendation we can give is for scleroderma patients to consult a scleroderma expert, since it is a rare illness with unusual complications and unique treatment concerns. ISN.
Types of Scleroderma. Symptoms, treatments and prognosis for scleroderma vary drastically based on the type of scleroderma. ISN.
See a scleroderma expert to apply for enrollment in clinical trials
Scleroderma Experts: EUSTAR and SCTC Worldwide Listings. Scleroderma is a rare disease so it is best to consult an expert as soon as possible to be assured of the latest treatment information, and for the opportunity to enroll in clinical trials.
Elevating standards of care for scleroderma throughout the world.
The Scleroderma Care and Research Journal (SCAR) is published by the Scleroderma Clinical Trials Consortium (SCTC). The SCTC is a nonprofit group of international scleroderma researchers. This journal elevates standards of care for scleroderma by covering topics of interest for rheumatologists and others involved in scleroderma clinical care worldwide.
SCLERO.ORG is brought to you by the nonprofit International Scleroderma Network (ISN). The ISN is a full-service nonprofit scleroderma charitable foundation providing stellar research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension.
